Open AccessClozapina en epilepsia y psicosis: efectos en las crisis epilépticas y en el perfil metabólico
Author(s) -
Edgar Daniel Crail-Meléndez,
María Isabel Frausto-Luján,
Carlos L Aviña-Cervantes,
Iris E. MartínezJuárez,
Daniela Cruz-Peralta
Publication year - 2021
Publication title -
revista medica del instituto mexicano del seguro social/revista médica del instituto mexicano del seguro social
Language(s) - Spanish
Resource type - Journals
eISSN - 2448-5667
pISSN - 0443-5117
DOI - 10.24875/rmimss.m21000048
Subject(s) - medicine
Clozapine (CZP) is an antipsychotic used in resistant psychosis, but has adverse metabolic effects and is associated with new onset or worsening of epileptic seizures (ES). There is not enough information available regarding its effect on metabolic variables and on ES in patients with epilepsy.